The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 03, 2025 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Agrawal, trustee of Aayush Agrawal Trust and a promoter of Ajanta Pharma Ltd, has created a fresh pledge on 4,65,000 shares (0.37% of total share capital) on March 28, 2025. The reason given for the pledge is a change in lender, with Jio Finance Ltd being the new financing institution. After this event, the trust's total encumbered shares stand at 52,30,002 (4.19% of share capital), up from 47,65,002 (3.81%) earlier. Aayush Agrawal Trust's overall promoter holding in the company remains 1,41,12,924 shares (11.30%). The disclosure was filed under SEBI (SAST) Regulation 31(1) and 31(2).
This is essentially a refinancing move by the promoter — switching the lender for pledged shares with a small increase in pledged quantity. It is a routine disclosure and does not indicate any sale, invocation, or reduction in promoter stake, so the direct impact on shareholders is minimal.